Skip to main content
SpringerLink
Log in

Haemovigilance

  • Chapter
Transfusion Medicine: Quo Vadis? What Has Been Achieved, What Is to Be Expected

Part of the book series: Developments in Hematology and Immunology ((DIHI,volume 36))

  • 88 Accesses

Abstract

The very first reported instance when vigorous preventative measures were taken because of a transfusion related accident occurred in the seventeenth cen-tury, in France [3-5]. This was a time when animal-to-man transfusions were

The contents of this paper do not necessarily reflect the views of the Société Franaisede Vigilance et de Thérapeutique Transfusionnelle.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Baudelot J and Djoudi R. De la carte d’information transfusionnelle à la traçabilité des produits. [From the transfusion information card to the tracing of blood products.] Cah Anesthesiol, 1994;42:379–83.

    PubMed  CAS  Google Scholar 

  2. Menitove JE. Hemovigilance in the United States of America. Vox Sang 1998;74 Suppl 2:447–55.

    Article  PubMed  Google Scholar 

  3. Denis J. Concerning a new way of curing sundry diseases by transfusion of blood. Philosophical Transactions of the Royal Society of London. 1667;3:489–504.

    Google Scholar 

  4. Denis J. An extract of a letter written by J. Denis, Doctor of Physics and Professor of Philosophy and the Mathematics at Paris, touching a late cure of an inveterate phrensy by the transfusion of blood. Philosophical Transactions of the Royal Society of London. 1668:4:710.

    Google Scholar 

  5. Bernard J. La légende du sang. Flammarion: Paris, 1992. ISBN 2–08–035152–4.

    Google Scholar 

  6. Décret nº 94–68 du 24 janvier 1994 relatif aux régles d’hémovigilance. Official journal of the French Republic, 26th January 1994, pages 1346–49.

    Google Scholar 

  7. Haeman Consortium, for the European Commission. The establishment of a haemovigilance network in the European Community. A feasibility project. Luemburg. December 1998.

    Google Scholar 

  8. Keller-Stanilawski B. in “Le risque sanitaire en Europe: les systémes d’hémovigilance” — meeting of the Assistance Publique —; Hôpitaux de Paris, Paris, January 23, 2000.

    Google Scholar 

  9. Williamson LM, Lowe S, Love EM, et al. Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. BMJ 1999;319:16–19.

    Article  PubMed  CAS  Google Scholar 

  10. http://www.fda.goc/cber/transfusion.htm

  11. National Haemovigilance Office. Annual report, 1999.http://www.ibsts.ie

  12. Rouger P, Le Pennec PY, Noizat-Pirenne F. Analyse des risques immunologiques en transfusion sanguine: période 1991–1998. Transfus Clin Biol 2000:7:9–14.

    CAS  Google Scholar 

  13. ingrand P, Surer-Pierres Houssay D, Salmi LR. Reliability of the pretransfusion bedside compatibility test: association with transfusion practice and training. Transfusion 1998;38:1030–36.

    Article  PubMed  CAS  Google Scholar 

  14. Morel P, Leconte des Floris MF, Bardiaux L, Pouthier F, Hervé P. Transfusion sanguine et risque bactérien. Transfus Clin Biol 2000;7: 5–23.

    Article  Google Scholar 

  15. Vassort-Bruneau C, Allouch P, Audurier A, et al. Efficacité d’une procédure de prélévement sur les contaminations bactériennes lors de la ponction veineuse. Transfus Clin Biol 1998;5:95S.

    Google Scholar 

  16. Heltberg O, Skov P, Gerner-Schmidt H. et al. Nosocomial epidemic of Serratia marcescens septicemia ascribed to contaminated blood transfusion bags. Transfusion 1993;33:221–27.

    Article  PubMed  CAS  Google Scholar 

  17. Faber JC L’hémovigilance en Europe. Transfus Clin Biol 2000:7:5–8.

    CAS  Google Scholar 

  18. http://www.ehn-org.net

Download references

Author information

Authors and Affiliations

  1. Société Française de Vigilance et de Thérapeutique Transfusionnelle, France

    N. Drouet

Authors
  1. N. Drouet
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Blood Bank Noord Nederland, Groningen, The Netherlands

    C. Th. Smit Sibinga

  2. Edinburgh, Scotland, UK

    J. D. Cash

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Drouet, N. (2001). Haemovigilance. In: Sibinga, C.T.S., Cash, J.D. (eds) Transfusion Medicine: Quo Vadis? What Has Been Achieved, What Is to Be Expected. Developments in Hematology and Immunology, vol 36. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1735-1_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-1735-1_15

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5700-1

  • Online ISBN: 978-1-4615-1735-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation